The results indicate that disparities in care and biases that
influence treatment may be based not just on immigration status but
also on race, said senior study author Dr. David Chang of Harvard
University and Massachusetts General Hospital in Boston.
Compared to white women born in the U.S., Hispanic women born in the
country were 18 percent more likely to be diagnosed when tumors had
already advanced to become more difficult to treat, and Hispanic
immigrants were 26 percent more likely to get a later diagnosis.
Hispanic immigrants were also 20 percent less likely to receive
radiation than white women born in the U.S., the study found.
"We will never be able to conclusively prove bias, but by
identifying disparities in treatment we are building strong
circumstantial evidence that human bias may play at least a partial
role," Chang added by email.
That's because the study didn't look at outcomes, which can be
influenced by genetics and a variety of other individual patient
characteristics. It looked at treatment choices doctors made.
Most early-stage breast cancer patients have surgery – either a
lumpectomy that removes malignant tissue while sparing the rest of
the breast or a mastectomy that removes the entire breast. After
surgery, they may also get chemotherapy or radiation to destroy any
remaining abnormal cells and reduce the risk of cancer coming back.
Treatment options can be more limited when tumors aren't caught
until the cancer is more advanced.
For the study, researchers examined data on about 296,000 women
diagnosed with breast cancer in the U.S. from 1988 to 2009.
They found U.S.-born Hispanic women had 15 percent lower odds of
receiving any form of radiation than white women born in the
country.
To separate the effects of ethnicity or race from the effect of
having been born outside the U.S., researchers also compared
foreign-born Hispanic women to foreign-born white women.
Immigration seemed to have the opposite effect for Hispanic and
white women, researchers report in JAMA Surgery. Among immigrants,
Hispanic women were significantly less likely to get radiation than
white patients. But white immigrant women were 26 percent more
likely to receive radiation than white women born in the U.S.
The study didn't examine treatment outcomes or explore how factors
such as insurance status or access to care close to home might
influence treatment options. The study also didn't look at other
things that may determine what care women get such as income,
education and English fluency.
[to top of second column] |
"Low income, low education immigrant groups are less likely to be
insured, have lower access to care and poorer outcomes," said Roshan
Bastani, director of cancer disparities research at the University
of California Los Angeles Jonsson Comprehensive Cancer Center.
"This study shows that among Latinas, being foreign born is an added
burden with regard to poor outcomes," Bastani, who wasn't involved
with the study, added by email.
Breast cancer treatment or outcomes might also vary for Hispanic
immigrants depending on their legal status in the U.S., said Dr.
Katherine Reeder-Hayes of the University of North Carolina Chapel
Hill Lineberger Comprehensive Cancer Center.
"The authors' findings confirm the logical hypothesis that Hispanic
patients born outside the United States may have more difficulty
accessing the U.S. healthcare system compared to other groups
including U.S.-born Hispanics," Reeder-Hayes, who wasn't involved in
the study, said by email.
"In the current climate it is also possible that undocumented
immigrants who presumably make up part but not all of the
foreign-born group may fear contact with the health system because
of their perception that it would create problems related to their
immigration status," Reeder-Hayes added. "Unfortunately, we should
probably worry that some foreign born patients may delay seeking
care due to these types of concerns."
SOURCE: http://bit.ly/2ldGpPn JAMA Surgery, online February 8, 2017.
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|